When it comes to biologics, quality is not just important, it is everything. Unlike small molecules, biologics are produced by living systems, which makes them more complex, more variable and more sensitive to manufacturing conditions. To ensure safety and efficacy, regulators require companies to define and monitor Critical Quality Attributes (CQAs) throughout development and production.

At 53Biologics, we see CQAs as the blueprint of product quality. By identifying them early and controlling them consistently, biotech companies can navigate development more smoothly, avoid costly delays and build trust with regulatory authorities.

1. What Are Critical Quality Attributes (CQAs)?

CQAs are the measurable physical, chemical, biological or microbiological properties that must stay within defined limits to guarantee the desired product quality. They are directly linked to safety, efficacy and patient outcomes.

Examples of CQAs in biologics include:

• Potency: ensuring the biologic performs its intended function.
• Purity: minimizing impurities like host cell proteins, DNA, or endotoxins.
• Stability: monitoring aggregation or degradation over time.
• Post-translational modifications: such as glycosylation in monoclonal antibodies, which can affect function and immunogenicity.

By defining CQAs, companies create the foundation for reliable and reproducible biologics production.

2. The Role of Quality by Design (QbD)

CQAs are central to the Quality by Design (QbD) approach encouraged by regulatory bodies. QbD emphasizes building quality into the process rather than relying on final product testing alone.

• Link to Critical Process Parameters (CPPs): For example, temperature or pH in a bioreactor directly impact glycosylation patterns, which are a CQA.
• Risk-based development: Identifying which parameters have the greatest influence on CQAs helps companies focus resources effectively.
• Regulatory acceptance: A QbD approach not only strengthens quality but also accelerates regulatory approval.

In short, controlling CQAs is not just good science, it is good business.

3. How CDMOs Help Manage CQAs

For many biotech companies, especially startups, defining and controlling CQAs can feel overwhelming. This is where CDMOs add real value. At 53Biologics, we support clients by:

• Developing analytical methods: Designing assays to measure potency, purity and stability.
• Validating processes under GMP: Ensuring methods meet EMA and FDA standards.
• In-process monitoring: Tracking CQAs during production to detect deviations early.
• Regulatory alignment: Implementing ICH Q8, Q9 and Q10 guidelines to ensure compliance across markets.

Our integrated teams work hand-in-hand with clients, from cell line development to GMP manufacturing, to safeguard critical attributes at every step.

4. Why CQAs Matter for the Future of Biologics

As biologics become more complex, think bispecific antibodies, fusion proteins, or advanced cell and gene therapies, defining CQAs will only become more important. Emerging technologies such as real-time monitoring, AI-driven analytics and digital twins will enhance the ability to track and control these attributes in real time, driving both compliance and innovation.

Critical Quality Attributes are more than regulatory requirements, they are the key to ensuring that every biologic is safe, effective and reproducible. By embedding CQAs into development and manufacturing strategies, companies can accelerate timelines and reduce risk.

At 53Biologics, we specialize in defining, monitoring and controlling CQAs throughout the entire product lifecycle. Our expertise in GMP manufacturing helps our clients bring biologics to market with confidence

About us:

53Biologics is a Spanish CDMO specialized in decoding biologics production, from DNA to proteins. The company provide services from preclinical development to GMP manufacturing, supporting their clients in getting their biological products to market as quickly as possible.

For more information or to speak with one of our experts, fill out our contact form or email us at info@53biologics.com.